FTXH
FTXH
About First Trust Nasdaq Pharmaceuticals ETF
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within...
About First Trust Nasdaq Pharmaceuticals ETF
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GILD | Gilead Sciences, Inc. | 0.00% | 8.74K | $1.13M |
 MEDP | Medpace Holdings, Inc. | 0.00% | 1.02K | $545.28K |
 MIRM | Mirum Pharmaceuticals, Inc. | 0.00% | 1.94K | $234.16K |
 MRK | Merck & Co., Inc. | 0.00% | 21.02K | $2.54M |
 MRNA | Moderna, Inc. | 0.00% | 3.34K | $225.05K |
 NBIX | Neurocrine Biosciences, Inc. | 0.00% | 3.10K | $532.29K |
 SUPN | Supernus Pharmaceuticals, Inc. | 0.00% | 3.27K | $152.39K |
 SYRE | Spyre Therapeutics, Inc. | 0.00% | 4.16K | $411.24K |
 TARS | Tarsus Pharmaceuticals, Inc. | 0.00% | 2.37K | $132.81K |
 BIIB | Biogen Inc. | 0.00% | 6.78K | $1.30M |
 TGTX | TG Therapeutics, Inc. | 0.00% | 5.95K | $326.05K |
 TVTX | Travere Therapeutics, Inc. | 0.00% | 6.01K | $342.36K |
 TWST | Twist Bioscience Corporation | 0.00% | 3.81K | $352.45K |
 TXG | 10x Genomics, Inc. | 0.00% | 7.76K | $355.10K |
 BMY | Bristol-Myers Squibb Company | 0.00% | 41.73K | $2.37M |
 BMRN | BioMarin Pharmaceutical Inc. | 0.00% | 7.44K | $435.87K |
 CAH | Cardinal Health, Inc. | 0.00% | 5.68K | $1.30M |
 CPRX | Catalyst Pharmaceuticals, Inc. | 0.00% | 7.76K | $243.86K |
 CRL | Charles River Laboratories International, Inc. | 0.00% | 2.50K | $578.49K |
 GH | Guardant Health, Inc. | 0.00% | 1.91K | $304.69K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
United KingdomSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland United KingdomHoldings (Top 20)
GILD
Gilead Sciences, Inc.
MEDP
Medpace Holdings, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
MRK
Merck & Co., Inc.
MRNA
Moderna, Inc.
NBIX
Neurocrine Biosciences, Inc.
SUPN
Supernus Pharmaceuticals, Inc.
SYRE
Spyre Therapeutics, Inc.
TARS
Tarsus Pharmaceuticals, Inc.
BIIB
Biogen Inc.
TGTX
TG Therapeutics, Inc.
TVTX
Travere Therapeutics, Inc.
TWST
Twist Bioscience Corporation
TXG
10x Genomics, Inc.
BMY
Bristol-Myers Squibb Company
BMRN
BioMarin Pharmaceutical Inc.
CAH
Cardinal Health, Inc.
CPRX
Catalyst Pharmaceuticals, Inc.
CRL
Charles River Laboratories International, Inc.
GH
Guardant Health, Inc.